Once-weekly exenatide versus once- or twice-daily insulin detemir: randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas (Q36782811)

From Wikidata
Jump to navigation Jump to search
scientific article published on 28 December 2012
edit
Language Label Description Also known as
English
Once-weekly exenatide versus once- or twice-daily insulin detemir: randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas
scientific article published on 28 December 2012

    Statements

    Once-weekly exenatide versus once- or twice-daily insulin detemir: randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas (English)
    0 references
    0 references
    Seamus Sreenan
    Hélène Sapin
    Omolara Adetunji
    Arash Tahbaz
    Jiten Vora
    28 December 2012
    1368-1376

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit